Methylphenidate Hydrochloride Tablet, Extended Release — FDA Drug Shortage

Current — Trigen Laboratories, LLC

The FDA lists a drug shortage record for Methylphenidate Hydrochloride Tablet, Extended Release (tablet) from Trigen Laboratories, LLC with status Current. The shortage was first posted on Jul 26, 2023. Reported reason: Demand increase for the drug

Shortage details

Status
Current
Company
Trigen Laboratories, LLC
Package NDC
13811-709-10
Dosage Form
Tablet
Presentation
Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 13811-709-10)
Initial Posting
Jul 26, 2023

Reason

Demand increase for the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.